← Back to Search

Device

The Neovasc Reducer™ System for Nephrotic Syndrome (Reducer Trial)

N/A
Waitlist Available
Research Sponsored by Amir Lerman
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 4 months post reducer implantation
Awards & highlights

Reducer Trial Summary

This trial is testing a new implantable device to see if it can improve symptoms and quality of life for patients with coronary microvascular dysfunction.

Reducer Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 4 months post reducer implantation
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 4 months post reducer implantation for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Coronary Flow Reserve (CFR)
Change in Index of Myocardial Resistance (IMR)

Reducer Trial Design

1Treatment groups
Experimental Treatment
Group I: Chronic Refractory AnginaExperimental Treatment1 Intervention
Subjects with chronic refractory angina will undergo implantation of the Neovasc Reducer™ System in the cardiac catheterization laboratory.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
The Neovasc Reducer™ System
2021
N/A
~30

Find a Location

Who is running the clinical trial?

Amir LermanLead Sponsor

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Feasibility and Efficacy of Coronary Sinus Narrowing in Patients With Coronary Microvascular Dysfunction
Amir Lerman 2021. "Feasibility and Efficacy of Coronary Sinus Narrowing in Patients With Coronary Microvascular Dysfunction". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04523168.
~8 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top